Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ellen Lanckacker

1PUBLICATIONS

17CO-AUTHORS

Biologically active molecules

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 09, 2019

A small-molecule fusion inhibitor of influenza virus is orally active in mice.

Maria J P van Dongen, Rameshwar U Kadam, Jarek Juraszek

Pageof 1

Frequent Collaborators

1 joint publications

Maria J P van Dongen

1 joint publications

Rameshwar U Kadam

1 joint publications

Jarek Juraszek

1 joint publications

Edward Lawson

1 joint publications

Boerries Brandenburg

1 joint publications

Frederike Schmitz

1 joint publications

Wim B G Schepens

1 joint publications

Bart Stoops

1 joint publications

Harry A van Diepen

1 joint publications

Chan Tang

Frequent Collaborators

1 joint publications

Maria J P van Dongen

1 joint publications

Rameshwar U Kadam

1 joint publications

Jarek Juraszek

1 joint publications

Edward Lawson

Top Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

See more related videos

Top Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

See more related videos